These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16206181

  • 1. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
    Nair SG, Gudelsky GA.
    Synapse; 2005 Dec 15; 58(4):229-35. PubMed ID: 16206181
    [Abstract] [Full Text] [Related]

  • 2. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
    Nair SG, Gudelsky GA.
    Brain Res Bull; 2006 Apr 28; 69(4):382-7. PubMed ID: 16624669
    [Abstract] [Full Text] [Related]

  • 3. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
    Nair SG, Gudelsky GA.
    Synapse; 2004 Sep 15; 53(4):202-7. PubMed ID: 15266551
    [Abstract] [Full Text] [Related]

  • 4. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S.
    Neurotoxicology; 2008 Nov 15; 29(6):1030-6. PubMed ID: 18722468
    [Abstract] [Full Text] [Related]

  • 5. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.
    Nair SG, Gudelsky GA.
    Psychopharmacology (Berl); 2006 Jan 15; 184(2):182-9. PubMed ID: 16378215
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG, Gudelsky GA.
    Brain Res; 2004 Jul 09; 1013(2):168-73. PubMed ID: 15193525
    [Abstract] [Full Text] [Related]

  • 7. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG, Yamamoto BK.
    J Neurochem; 2004 Nov 09; 91(4):852-9. PubMed ID: 15525339
    [Abstract] [Full Text] [Related]

  • 8. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M, Goñi-Allo B, Aguirre N.
    Neuropsychopharmacology; 2005 Dec 09; 30(12):2180-91. PubMed ID: 15841107
    [Abstract] [Full Text] [Related]

  • 9. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
    Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R.
    J Neurochem; 2004 Dec 09; 91(6):1473-82. PubMed ID: 15584923
    [Abstract] [Full Text] [Related]

  • 10. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
    Laplante F, Srivastava LK, Quirion R.
    J Neurochem; 2004 Apr 09; 89(2):314-23. PubMed ID: 15056275
    [Abstract] [Full Text] [Related]

  • 11. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A, Acquas E, Fenu S, Di Chiara G.
    Neuropharmacology; 2006 May 09; 50(6):661-70. PubMed ID: 16427098
    [Abstract] [Full Text] [Related]

  • 12. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
    Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):155-60. PubMed ID: 17258195
    [Abstract] [Full Text] [Related]

  • 13. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ, Huang M, Li Z, Dai J, Meltzer HY.
    Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654
    [Abstract] [Full Text] [Related]

  • 14. Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors.
    Consolo S, Arnaboldi S, Ramponi S, Nannini L, Ladinsky H, Baldi G.
    J Pharmacol Exp Ther; 1996 May 12; 277(2):823-30. PubMed ID: 8627564
    [Abstract] [Full Text] [Related]

  • 15. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC, Arnold JC, McGregor IS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 12; 29(5):648-57. PubMed ID: 15908091
    [Abstract] [Full Text] [Related]

  • 16. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK, Nash JF, Gudelsky GA.
    J Pharmacol Exp Ther; 1995 Jun 12; 273(3):1063-70. PubMed ID: 7791076
    [Abstract] [Full Text] [Related]

  • 17. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
    Acquas E, Wilson C, Fibiger HC.
    J Pharmacol Exp Ther; 1997 Apr 12; 281(1):360-8. PubMed ID: 9103518
    [Abstract] [Full Text] [Related]

  • 18. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM, Cathala A, Neny M, Rouge-Pont F, Drago F, Piazza PV, Spampinato U.
    J Neurochem; 2009 Oct 12; 111(2):614-23. PubMed ID: 19702657
    [Abstract] [Full Text] [Related]

  • 19. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Ann N Y Acad Sci; 2004 Oct 12; 1025():189-97. PubMed ID: 15542717
    [Abstract] [Full Text] [Related]

  • 20. Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors.
    Imperato A, Obinu MC, Casu MA, Mascia MS, Dazzi L, Gessa GL.
    J Pharmacol Exp Ther; 1993 Aug 12; 266(2):557-62. PubMed ID: 8102643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.